Jason Mallory, PhD
Vice President, Clinical Development
Jason Mallory is the Vice President of Clinical Development at Kriya Therapeutics. Dr. Mallory joins Kriya from Spark Therapeutics, where he was a Clinical Development Leader, focused on liver-targeted AAV clinical programs (Pompe disease, Hemophilia A, and early-stage programs). Prior to Spark Therapeutics, Dr. Mallory led clinical development activities spanning all phases of drug development for gene therapy programs at GlaxoSmithKline (Libmeldy™ for patients with metachromatic leukodystrophy) and Adverum Biotechnologies. Prior to his experience in the development of gene therapies for rare diseases, Dr. Mallory spent approximately ten years in clinical development of medicines for common diseases, including contributing to the development and successful global licensure of albiglutide (a GLP-1 receptor agonist) for patients with type 2 diabetes mellitus.
Dr. Mallory received his PhD in molecular biology and genetics from Baylor University and completed postdoctoral work at the University of Texas Southwestern Medical Center and the Institute of Metabolic Disease at Baylor University Medical Center. Dr. Mallory received his undergraduate degree Biology from Midwestern State University, Wichita Falls.